VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
JBS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
JBSJbs N.V.
$12.10$26.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksJBSCash Flow

Jbs N.V. (JBS) Cash Flow Statement

12Y historyFree accessUpdated daily

Free cash flow swung from a 6.0% margin in 2024Q2 to negative 6.3% in 2026Q1, with working capital outflows of $7.1B in 2026Q1 indicating cash conversion that appears highly volatile.

Income StatementBalance SheetCash FlowRatios

JBS Cash Flow Statement

Annual statement

JBS Cash Flow Statement

Jbs N.V. (JBS) cash flow statement — 12-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Cash from Operations10.09B15.49B23.56B11.5B13.33B21.48B23.78B13.77B7.44B5.2B3.67B7.38B8.99B
Operating CF Margin %-3.29%5.65%3.16%3.47%5.93%8.8%6.73%4.1%3.19%2.15%4.53%7.46%
Operating CF Growth %-131.26%-34.23%104.87%-13.76%-37.93%-9.68%72.73%85%43.02%41.9%-50.34%-17.83%-
Net Income4.17B11.1B9.62B-1.06B15.46B20.49B4.6B6.07B25.2M534.2M233.56M4.64B2.04B
Depreciation & Amortization10.73B12.63B11.95B10.38B10.05B9.03B7.84B6.31B4.8B4.47B4.5B3.69B2.55B
Stock-Based Compensation89.13M085.6M34.42M39.13M63.43M-5.25M49.19M118.11M122.64M143.3M39.74M13.01M
Deferred Taxes397.39M-361.42M00000000000
Other Non-Cash Items1.31B3.99B9.24B-1.26B-3.36B12.74B13.37B4.71B4.52B1.95B599.92M-190.33M4.94B
Working Capital Changes-6.74B-11.86B-7.34B3.41B-8.85B-20.84B-2.02B-3.37B-2.02B-1.87B-1.81B-797.57M-548.12M
Change in Receivables1.88B-1.45B-2.02B3.13B-1.3B-4.27B778.49M-259.22M673.18M-234.03M-225.97M1.05B241.82M
Change in Inventory-3.3B-4.58B-4.73B-300.66M-6.78B-11.79B-3.53B-3.13B-2.13B-1.06B-1.16B-866.69M-1.61B
Change in Payables605.09M3.01B00000000000
Cash from Investing-10.97B-12.56B-7.73B-7.02B-13.12B-18.86B-7.83B-5.85B-1.74B-2.43B-3.54B-20.76B-4.28B
Capital Expenditures-11.16B-11.4B-8.08B-7.49B-11.23B-9.62B-5.99B-4.24B-2.83B-3.11B-3.48B-5.45B-3.57B
CapEx % of Revenue2.93%2.42%1.94%2.06%2.92%2.65%2.22%2.07%1.56%1.91%2.04%3.35%2.96%
Acquisitions240.09M394.77M-31.46M-17.16M-1.98B-9.34B-2.19B-2.24B-45.07M-1.85B-482.54M-15.47B0
Investments-------------
Other Investing62.52M-285.38M382.02M485.19M81.04M102.65M339.15M625.42M1.13B2.53B423.38M169.72M-707.41M
Cash from Financing2.96B-9.97B-7.3B5.01B-8.76B-844.5M-9.02B-6.44B-9.99B-634.37M-8.1B15.17B876.88M
Debt Issued (Net)8.3B7.15B-1.65B7.45B264.71M17.73B-5.6B-6.4B-9.5B-328.63M745.56M9B1.15B
Equity Issued (Net)-1.31B-3.19B-44.49M0-3.65B-10.6B-1.27B0-498.19M-255.94M-821.14M-1.78B-64.23M
Dividends Paid-1.3B-8.81B-4.44B-2.22B-4.44B-7.4B-1.44B-5.98M-126.88M-93.35M-1.1B-482.73M-219.88M
Share Repurchases-1.32B-3.19B-44.49M0-3.65B-10.6B-1.27B0-498.19M-255.94M-821.14M-1.78B-64.23M
Other Financing-2.74B-5.12B-1.16B-218.37M-939.51M-575.4M-712.53M-38.77M135.29M43.55M-6.92B8.42B7.03M
Net Change in Cash2.71B-5.71B12.64B8.94B-10.06B3.56B9.65B1.1B-2.81B2.39B-9.49B3.93B14.91B
Free Cash Flow-1.03B4.13B15.47B4.01B2.11B11.86B17.8B9.53B4.62B2.09B187.16M1.93B5.42B
FCF Margin %-0.27%0.88%3.71%1.1%0.55%3.27%6.59%4.66%2.54%1.28%0.11%1.19%4.5%
FCF Growth %-123.49%-73.32%286.2%90.15%-82.23%-33.37%86.75%106.46%120.61%1017.79%-90.31%-64.35%-
FCF per Share-1.013.866.981.810.934.786.703.571.730.740.070.671.88
FCF Conversion (FCF/Net Income)-0.25x1.40x2.45x-10.84x0.84x1.01x5.17x2.27x295.35x9.74x15.70x1.59x4.41x
Interest Paid803.59M08.02B6.44B4.8B3.94B3.5B3.6B4.4B3.91B4.12B4.14B0
Taxes Paid333.62M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Volatile operating cash flow amid leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-Q (2026Q3)

Operating Cash Flow Diverges Sharply From Earnings

According to reported cash flow figures, JBS's operating cash flow ran at 3.09 times net income in 2026Q3 and negative 8.34 times in 2026Q2, indicating earnings are not a reliable guide to cash generation in the near term.

The swings in the operating cash flow to net income ratio, which moved from 4.69 in 2025Q4 to negative values in 2026Q1 and 2026Q2, suggest that working capital movements and biological asset accounting are driving a large share of reported cash results. Net income was near zero or negative in 2026Q2, so the ratio is distorted by a small denominator and should be read as directional rather than precise. Investors should monitor whether operating cash flow stabilizes once the working capital build reverses, since sustained divergence would challenge the quality of reported earnings.

Free Cash Flow Turns Negative Amid Volatility

Based on reported figures, JBS's free cash flow margin swung from 5.5% in 2024Q3 to negative 6.3% in 2026Q1, with 2026Q3 at negative 0.2%, showing that cash generation has not held a stable trajectory.

The decline from consistently positive free cash flow in 2024 to a sharp negative print in 2026Q1, driven by roughly $4.1 billion of operating cash outflow, suggests the business is highly sensitive to working capital and livestock cycle timing. Recovery in 2025Q4 to a 4.7% margin shows the capacity for strong cash generation exists, but the subsequent reversal implies the trend is not yet durable. The results warrant further investigation into whether the 2026 weakness reflects temporary timing or a more structural margin problem.

Capital Spending Stays Moderate Relative to Revenue

As reported in financial statements, JBS's capital expenditure ran between 1.4% and 3.7% of revenue across recent quarters, with depreciation and amortization of roughly $3 billion to $5 billion per quarter exceeding most capex outlays.

Capex intensity appears modest relative to the scale of the business, and the quarterly depreciation charge consistently sits above capex, which may indicate the asset base is being maintained at or below replacement levels. This pattern could flatter near-term free cash flow, though it may also signal underinvestment if sustained over multiple years. Without a clear split between maintenance and growth spending in the supplied data, the appropriate level of reinvestment cannot be firmly established.

Working Capital Swings Dominate Cash Results

Based on reported figures, working capital changes ranged from a $7.1 billion outflow in 2026Q1 to a $2.9 billion inflow in 2025Q4, making them the single largest driver of quarterly operating cash flow volatility.

The magnitude of these swings relative to net income suggests that inventory and receivable management, including livestock purchasing timing, is central to reported cash generation. The reversal from heavy outflow in early 2026 to partial recovery later in the year indicates much of the cash variance may be timing-related rather than reflecting permanent changes in earnings power. Investors should monitor whether working capital normalizes, as persistent build would strain liquidity given the company's elevated leverage.

Shareholder Returns Constrained by Leverage

According to recent filings, JBS paid dividends of roughly $6.8 billion in 2025Q2 and $1.3 billion in buybacks in 2025Q4, but cash returns have been irregular and largely funded from periods of strong operating cash flow.

The large 2025Q2 dividend outflow, set against a quarter with only $2.9 billion of operating cash flow, suggests distributions were not fully covered by contemporaneous cash generation and may have depended on balance sheet flexibility. Acquisition spending has been modest in the supplied data, which may indicate a shift away from the prior M&A-heavy approach. Given a debt-to-equity ratio of 2.40, investors should weigh whether continued distributions can coexist with debt reduction, and whether the cash deployment pattern remains sustainable through the current cycle.

Cash Metrics May Overstate Underlying Stability

Based on reported figures, the 2025Q4 operating cash flow of $10.7 billion and 4.7% FCF margin may reflect favorable working capital timing rather than repeatable cash generation, given the subsequent swing to negative FCF.

Biological asset fair value changes and working capital movements can create non-cash or timing-driven swings that the cash flow statement does not fully separate from core operating performance. A short-seller would likely argue that the strong 2024 and late-2025 cash prints were flattered by inventory liquidation and payables stretch, which reversed sharply in 2026Q1. Investors should weigh whether the reported cash profile reflects durable economics or cyclical timing before extrapolating recent recoveries.

JBS — Frequently Asked Questions

Quick answers to the most common questions about buying JBS stock.

How much cash does Jbs N.V. (JBS) generate from operations?

Jbs N.V. (JBS) generated $15.49B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Jbs N.V.'s free cash flow?

Jbs N.V. (JBS) generated $4.13B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Jbs N.V.'s capital expenditure (CapEx)?

Jbs N.V. (JBS) spent $11.40B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Jbs N.V. distribute cash to shareholders?

In 2025, Jbs N.V. (JBS) returned $8.81B to shareholders via cash dividends and spent $3.19B on share repurchases. This shows the company's commitment to returning capital to its equity investors.